Skip to main content
Premium Trial:

Request an Annual Quote

The Year of Personal Genomics

A feature story in Discover magazine rounds up the progress that personal genomics companies have made in 2007, as well as what consumers should expect from them. Though some tests can make relatively concrete predictions (like Agendia's FDA-approved MammaPrint), SNP screening can only offer the probability of developing a certain disease. While companies like Decode and Navigenics can offer consumers a "more complete health profile," says the article, the current test "cannot predict for sure whether a person will develop a given disease." That's not news to GTO readers, of course, but it's a good story to pass on to your civilian friends.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.